- Home
- DRCT vs RADX Comparison
DRCT vs RADX Comparison
Compare DRCT & RADX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRCT
- RADX
- Stock Information
- Founded
- DRCT 2018
- RADX 2021
- Country
- DRCT United States
- RADX Australia
- Employees
- DRCT 79
- RADX N/A
- Industry
- DRCT Computer Software: Programming Data Processing
- RADX
- Sector
- DRCT Technology
- RADX
- Exchange
- DRCT Nasdaq
- RADX NYSE
- Market Cap
- DRCT 16.7M
- RADX 31.8M
- IPO Year
- DRCT 2022
- RADX N/A
- Fundamental
- Price
- DRCT $0.69
- RADX $4.06
- Analyst Decision
- DRCT Strong Buy
- RADX Strong Buy
- Analyst Count
- DRCT 1
- RADX 2
- Target Price
- DRCT $6.00
- RADX $13.50
- AVG Volume (30 Days)
- DRCT 2.9M
- RADX 29.1K
- Earning Date
- DRCT 05-06-2025
- RADX 02-26-2025
- Dividend Yield
- DRCT N/A
- RADX N/A
- EPS Growth
- DRCT N/A
- RADX N/A
- EPS
- DRCT N/A
- RADX N/A
- Revenue
- DRCT $48,170,000.00
- RADX $204,609.00
- Revenue This Year
- DRCT $53.01
- RADX N/A
- Revenue Next Year
- DRCT $11.11
- RADX N/A
- P/E Ratio
- DRCT N/A
- RADX N/A
- Revenue Growth
- DRCT N/A
- RADX N/A
- 52 Week Low
- DRCT $0.44
- RADX $3.50
- 52 Week High
- DRCT $6.59
- RADX $50.82
- Technical
- Relative Strength Index (RSI)
- DRCT 48.55
- RADX N/A
- Support Level
- DRCT $0.81
- RADX N/A
- Resistance Level
- DRCT $1.23
- RADX N/A
- Average True Range (ATR)
- DRCT 0.14
- RADX 0.00
- MACD
- DRCT 0.02
- RADX 0.00
- Stochastic Oscillator
- DRCT 26.24
- RADX 0.00
About DRCT Direct Digital Holdings Inc.
Direct Digital Holdings Inc is an end-to-end, full-service programmatic advertising platform primarily focused on providing advertising technology, data-driven campaign optimization, and other solutions to underserved and less efficient markets on both the buy-side and sell-side of the digital advertising ecosystem. The company operates two reportable segments: sell-side advertising, which includes the results of Colossus Media, and buy-side advertising, which includes the results of Orange 142 and Huddled Masses. All of the company's revenues are attributed to the United States.
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.